JP2018537503A5 - - Google Patents

Download PDF

Info

Publication number
JP2018537503A5
JP2018537503A5 JP2018531499A JP2018531499A JP2018537503A5 JP 2018537503 A5 JP2018537503 A5 JP 2018537503A5 JP 2018531499 A JP2018531499 A JP 2018531499A JP 2018531499 A JP2018531499 A JP 2018531499A JP 2018537503 A5 JP2018537503 A5 JP 2018537503A5
Authority
JP
Japan
Prior art keywords
percent
composition
topical composition
mixture
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018531499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018537503A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/067276 external-priority patent/WO2017106714A1/en
Publication of JP2018537503A publication Critical patent/JP2018537503A/ja
Publication of JP2018537503A5 publication Critical patent/JP2018537503A5/ja
Pending legal-status Critical Current

Links

JP2018531499A 2015-12-16 2016-12-16 末梢神経障害を治療するための方法及び組成物 Pending JP2018537503A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562268007P 2015-12-16 2015-12-16
US62/268,007 2015-12-16
PCT/US2016/067276 WO2017106714A1 (en) 2015-12-16 2016-12-16 Methods and compositions for treating peripheral neuropathy

Publications (2)

Publication Number Publication Date
JP2018537503A JP2018537503A (ja) 2018-12-20
JP2018537503A5 true JP2018537503A5 (enExample) 2020-01-30

Family

ID=59057641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018531499A Pending JP2018537503A (ja) 2015-12-16 2016-12-16 末梢神経障害を治療するための方法及び組成物

Country Status (4)

Country Link
US (1) US20180369174A1 (enExample)
JP (1) JP2018537503A (enExample)
CA (1) CA3045004A1 (enExample)
WO (1) WO2017106714A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107614061A (zh) 2014-12-01 2018-01-19 阿科莱尔斯疗法公司 用于治疗与疼痛有关的偏头痛和病症方法和组合物
US12005034B2 (en) 2017-04-25 2024-06-11 Algotherapeutix Topical pharmaceutical composition comprising at least amitriptyline, for the treatment of peripheral neuropathic pain
EP3651753A4 (en) * 2017-07-11 2021-05-05 University Of Miami TOPICAL ACETAMINOPHEN FORMULATIONS FOR RELIEF ITCHING
CN112206222A (zh) * 2018-11-09 2021-01-12 北京德默高科医药技术有限公司 含有布洛芬结构类似物的多层经皮给药系统
AU2020333860A1 (en) * 2019-08-21 2022-04-07 Leo Pharma A/S Solvent delivery system for topical delivery of active agents
FR3108841B1 (fr) 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
EP3907214A1 (en) * 2020-05-04 2021-11-10 Dompe' Farmaceutici S.P.A. Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use
PL4114403T3 (pl) * 2021-05-24 2023-10-09 Medicon Pharmaceuticals, Inc. Leczenie bólu neuropatycznego towarzyszącego neuropatii obwodowej indukowanej przez chemioterapię
RS64402B1 (sr) 2021-05-24 2023-08-31 Medicon Pharmaceuticals Inc Lečenje bola povezanog sa dijabetičkom perifernom neuropatijom
CN117357502B (zh) * 2023-11-26 2024-09-03 重庆医科大学 甲磺酸去铁胺在制备预防或治疗神经病理性疼痛药物中的应用
US12678470B2 (en) 2024-08-08 2026-07-14 Angela Chatman Multi-purpose medicinal cream

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
DE10340740A1 (de) * 2003-09-04 2005-03-31 Degussa Food Ingredients Gmbh Physiologisch aktive Zusammensetzung auf Phosphatidylserin-Basis
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
ES2589915T3 (es) * 2008-10-08 2016-11-17 Xgene Pharmaceutical Inc Conjugados de GABA y métodos de utilización de los mismos
US20130209585A1 (en) * 2012-02-13 2013-08-15 Stanley Kim Topical NMDA Antagonist Formulations for the Treatment of Peripheral Neuropathy
US8822537B2 (en) * 2012-09-27 2014-09-02 Achelios Therapeutics, Inc. Topical ketoprofen composition
CA2894696A1 (en) * 2012-12-21 2014-06-26 Teikoku Pharma Usa, Inc. Compositions and methods for transdermal delivery of hormones and other medicinal agents

Similar Documents

Publication Publication Date Title
CA2662434C (en) Topical nsaid compositions with increased solubility
ES2248042T5 (es) Composición tópica que comprende n-acetilglucosamina.
US10201509B2 (en) Anti-acne formulation
JP5377326B2 (ja) ウシ類と他の動物における炎症を処置するための薬学的組成物および方法
JP6989489B2 (ja) Ｎｓａｉｄのための固溶体組成物
JP2010521442A (ja) 局所製剤処方
TR201819658T4 (tr) Akne Lezyonlarını Tedavi Etmek İçin Adapalen Ve Benzoil Peroksit Kombinasyonu
US10869818B2 (en) Foamable skin composition
JP2008531693A5 (enExample)
SA516380264B1 (ar) (s) -بيرليندول وأملاحه المقبولة صيدلانياً للاستخدام في الدواء
US10028927B2 (en) Topical pharmaceutical formulation
CN101541321A (zh) 局部用组合物
JP2005529947A5 (enExample)
KR20190072529A (ko) 국소 소염성 조성물
US11452701B2 (en) Topical emulsion composition containing nonsteroidal anti-inflammatory drug
AU2015224534B2 (en) Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Joseph et al. Pharmacotherapy for host modulation in periodontal disease: A review
US20180271813A1 (en) Sprayable analgesic compositions
Thielitz et al. Topical Retinoids
HK40037592B (en) Topical emulsion composition containing nonsteroidal anti-inflammatory drug
HK40037592A (en) Topical emulsion composition containing nonsteroidal anti-inflammatory drug
Thompson Fish oils effective alternative to NSAIDs for back pain
WO2018164566A1 (es) Composición y método para el tratamiento tópico del acné severo
HK1219877B (en) Acne solution
AR067700A1 (es) Composicion farmaceutica que comprende la combinacin de un agente antimicrobiano y un agente inhibidor selectivo de la enzima encefalinasa indicada para el contol y tratamiento de la diarrea aguda de origen bacteriano